Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease

Incidence of liver‐related morbidity and mortality in a population cohort of non‐alcoholic fatty liver disease

(2021) Ville T. Männistö et al.   LIVER INTERNATIONAL

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

(2021) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance

(2021) Sebastian Hörber et al.   Molecular Metabolism

Association of Hepatic Steatosis with Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease

(2020) Nandini M. Meyersohn et al.   Clinical Gastroenterology and Hepatology

Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

(2019) Peter Lykke Eriksen et al.   Clinics and Research in Hepatology and Gastroenterology

Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study

(2019) Peter Lykke Eriksen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Platelet Characteristics in Patients with Essential Thrombocytosis

(2018) Oliver Heidmann Pedersen et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy

(2018) Wael Sumaya et al.   EUROPEAN HEART JOURNAL

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Fibrin clot lysis assay: Establishment of a reference interval

(2018) Søs Neergaard-Petersen et al.   THROMBOSIS RESEARCH

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

(2017) Armando Tripodi et al.   JOURNAL OF HEPATOLOGY

Reply to: “Procoagulant imbalance in patients with non-alcoholic fatty liver disease”

(2017) Wilma Potze et al.   JOURNAL OF HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Preserved hemostatic status in patients with non-alcoholic fatty liver disease

(2016) Wilma Potze et al.   JOURNAL OF HEPATOLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

(2015) Chiara Rosso et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis

(2015) Jonathan G. Stine et al.   LIVER TRANSPLANTATION

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

(2014) Armando Tripodi et al.   JOURNAL OF HEPATOLOGY

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

(2014) Søs Neergaard-Petersen et al.   THROMBOSIS AND HAEMOSTASIS

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2013) An Verrijken et al.   HEPATOLOGY

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Propensity for young reticulated platelet recruitment into arterial thrombi

(2013) Robert D. McBane et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease

(2012) Mehmet Celikbilek et al.   PLATELETS

Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry

(2012) Peter Rubak et al.   THROMBOSIS RESEARCH

Reduced clot-stability during the first 6hours after aneurysmal subarachnoid haemorrhage – a prospective case-control study

(2012) Carl C. Larsen et al.   THROMBOSIS RESEARCH

Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis

(2011) Naim Alkhouri et al.   HEPATOLOGY

Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease

(2010) Anna Kotronen et al.   LIVER INTERNATIONAL

High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism

(2010) Matteo Nicola Dario Di Minno   WORLD JOURNAL OF GASTROENTEROLOGY

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

(2009) Silvia Sookoian et al.   ATHEROSCLEROSIS

Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men

(2009) Mirjam E. Meltzer et al.   BRITISH JOURNAL OF HAEMATOLOGY